Demo Data from EDBT 2026 / reviewers in the wild / expert
Lucy F. Stead
dblp:32/9983
· DBLP profile ↗
3ranked-venue papers
1as first author
1since 2021 · last 2026
0000-0002-9550-4150ORCID · corroborated
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 3 · 1 first-author · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
3 papers |
Bioinformatics and computational biology · 100% |
Topics — the 5 heaviest of 6, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology
epigenomics |
1.0 | 1 | 2026 | ChromCall: assigning chromatin status to defined genomic regions using epigenomic profiling data · Bioinform. 2026 |
Bioinformatics and computational biology › epigenomics
histone modification analysis |
1.0 | 1 | 2026 | ChromCall: assigning chromatin status to defined genomic regions using epigenomic profiling data · Bioinform. 2026 |
Bioinformatics and computational biology › genome annotation
region annotation |
1.0 | 1 | 2026 | ChromCall: assigning chromatin status to defined genomic regions using epigenomic profiling data · Bioinform. 2026 |
Bioinformatics and computational biology
cancer genomics |
0.4 | 1 | 2019 | Simulation of heterogeneous tumour genomes with HeteroGenesis and in silico whole exome sequencing · Bioinform. 2019 |
Bioinformatics and computational biology › statistical genetics › variant effect prediction
genetic variant effect prediction |
0.1 | 1 | 2011 | KvSNP: accurately predicting the effect of genetic variants in voltage-gated potassium channels · Bioinform. 2011 |
Methods — techniques the papers use, named apart from their topics
enrichment analysis · 1.0ChIP-seq analysis · 1.0weighted-wessim · 0.4machine learning classification · 0.1
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2026 | ChromCall: assigning chromatin status to defined genomic regions using epigenomic profiling dataabstractMOTIVATION: Chromatin regulation is crucial for modulating gene expression and cellular function by altering DNA accessibility. Defining and understanding chromatin regulation across diverse biological conditions, including health and disease, requires quantification of both the presence and enrichment level of diverse DNA-binding factors and chromatin modifications across defined genomic regions. Existing approaches mainly rely on peak-based or genome-wide models, which identify high-signal regions but do not annotate chromatin status at predefined functional genomic regions, such as promoters or enhancers. This lack of region-based annotation limits downstream comparative and integrative analyses across multiple factors and datasets, prompting us to create ChromCall. RESULTS: ChromCall is an R package for region-based chromatin enrichment analysis that provides a robust and extensible foundation for transparent and reproducible epigenomic profiling at predefined genomic regions. We applied ChromCall to ChIP-seq data from glioblastoma (GBM) brain tumours and found that the promoters of genes implicated in treatment resistance are significantly more likely to exhibit a combination of histone marks associated with phenotypic plasticity. This highlights a potential novel mechanism of therapeutic escape in these deadly tumours. AVAILABILITY AND IMPLEMENTATION: The R package is available on https://github.com/GliomaGenomics/ChromCall and the version used in this paper is archived at https://doi.org/10.5281/zenodo.19580967. Muna Al-Jabri, Udayaraja Gk, Alastair P. Droop, Lucy F. Stead |
Bioinform. | 5 |
| 2019 | Simulation of heterogeneous tumour genomes with HeteroGenesis and in silico whole exome sequencingabstractSUMMARY: Tumour evolution results in progressive cancer phenotypes such as metastatic spread and treatment resistance. To better treat cancers, we must characterize tumour evolution and the genetic events that confer progressive phenotypes. This is facilitated by high coverage genome or exome sequencing. However, the best approach by which, or indeed whether, these data can be used to accurately model and interpret underlying evolutionary dynamics is yet to be confirmed. Establishing this requires sequencing data from appropriately heterogeneous tumours in which the exact trajectory and combination of events occurring throughout its evolution are known. We therefore developed HeteroGenesis: a tool to generate realistically evolved tumour genomes, which can be sequenced using weighted-Wessim (w-Wessim), an in silico exome sequencing tool that we have adapted from previous methods. HeteroGenesis simulates more complex and realistic heterogeneous tumour genomes than existing methods, can model different evolutionary dynamics, and enables the creation of multi-region and longitudinal data. AVAILABILITY AND IMPLEMENTATION: HeteroGenesis and w-Wessim are freely available under the GNU General Public Licence from https://github.com/GeorgetteTanner, implemented in Python and supported on linux and MS Windows. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Georgette Tanner, David R. Westhead, Alastair P. Droop, Lucy F. Stead |
Bioinform. | 4 |
| 2011 | KvSNP: accurately predicting the effect of genetic variants in voltage-gated potassium channelsabstractMOTIVATION: Non-synonymous single nucleotide polymorphisms (nsSNPs) in voltage-gated potassium (Kv) channels cause diseases with potentially fatal consequences in seemingly healthy individuals. Identifying disease-causing genetic variation will aid presymptomatic diagnosis and treatment of such disorders. NsSNP-effect predictors are hypothesized to perform best when developed for specific gene families. We, thus, created KvSNP: a method that assigns a disease-causing probability to Kv-channel nsSNPs. RESULTS: KvSNP outperforms popular non gene-family-specific methods (SNPs&GO, SIFT and Polyphen) in predicting the disease potential of Kv-channel variants, according to all tested metrics (accuracy, Matthews correlation coefficient and area under receiver operator characteristic curve). Most significantly, it increases the separation of the median predicted disease probabilities between benign and disease-causing SNPs by 26% on the next-best competitor. KvSNP has ranked 172 uncharacterized Kv-channel nsSNPs by disease-causing probability. AVAILABILITY AND IMPLEMENTATION: KvSNP, a WEKA implementation is available at www.bioinformatics.leeds.ac.uk/KvDB/KvSNP.html. CONTACT: [email protected] SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Lucy F. Stead, I. C. Wood, David R. Westhead |
Bioinform. | 1 |